Jan Cools

21.5k total citations
185 papers, 8.5k citations indexed

About

Jan Cools is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jan Cools has authored 185 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Hematology, 63 papers in Molecular Biology and 50 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jan Cools's work include Chronic Myeloid Leukemia Treatments (72 papers), Acute Lymphoblastic Leukemia research (50 papers) and Acute Myeloid Leukemia Research (43 papers). Jan Cools is often cited by papers focused on Chronic Myeloid Leukemia Treatments (72 papers), Acute Lymphoblastic Leukemia research (50 papers) and Acute Myeloid Leukemia Research (43 papers). Jan Cools collaborates with scholars based in Belgium, United States and France. Jan Cools's co-authors include Peter Marynen, Nicole Mentens, Iwona Włodarska, Peter Vandenberghe, Kim De Keersmaecker, D. Gary Gilliland, Carmen Vicente, Jason Gotlib, Lucienne Michaux and Maria Dêbiec‐Rychter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Jan Cools

179 papers receiving 8.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Cools Belgium 55 3.0k 2.8k 1.8k 1.8k 1.6k 185 8.5k
Bertil Johansson Sweden 55 4.5k 1.5× 4.5k 1.6× 1.9k 1.1× 547 0.3× 2.9k 1.8× 233 10.8k
Charlotte M. Niemeyer Germany 54 4.1k 1.4× 4.8k 1.7× 1.6k 0.9× 408 0.2× 2.0k 1.3× 260 10.3k
Wolf‐Karsten Hofmann Germany 42 2.9k 1.0× 2.6k 0.9× 768 0.4× 682 0.4× 718 0.5× 251 6.7k
Catriona Jamieson United States 42 6.7k 2.2× 3.4k 1.2× 4.1k 2.2× 822 0.5× 466 0.3× 187 12.2k
Eunice S. Wang United States 46 3.0k 1.0× 3.1k 1.1× 1.8k 1.0× 566 0.3× 790 0.5× 343 7.1k
Letizia Foroni United Kingdom 46 2.3k 0.8× 6.1k 2.1× 1.6k 0.9× 1.8k 1.0× 3.2k 2.1× 186 9.9k
Brian J.P. Huntly United Kingdom 42 4.3k 1.4× 3.7k 1.3× 1.1k 0.6× 748 0.4× 508 0.3× 112 7.5k
Ulrich Jaeger Austria 41 1.8k 0.6× 1.4k 0.5× 2.2k 1.2× 305 0.2× 507 0.3× 210 7.0k
Javier Pinilla‐Ibarz United States 41 1.9k 0.6× 2.6k 0.9× 1.8k 1.0× 986 0.5× 423 0.3× 236 5.8k
Vincent H. J. van der Velden Netherlands 45 2.4k 0.8× 5.1k 1.8× 1.4k 0.8× 394 0.2× 3.8k 2.4× 168 8.5k

Countries citing papers authored by Jan Cools

Since Specialization
Citations

This map shows the geographic impact of Jan Cools's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Cools with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Cools more than expected).

Fields of papers citing papers by Jan Cools

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Cools. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Cools. The network helps show where Jan Cools may publish in the future.

Co-authorship network of co-authors of Jan Cools

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Cools. A scholar is included among the top collaborators of Jan Cools based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Cools. Jan Cools is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Demeyer, Sofie, Nicole Mentens, Kris Jacobs, et al.. (2025). TLE4 is a repressor of the oncogenic activity of TLX3 in T-cell acute lymphoblastic leukemia. Leukemia. 39(3). 568–576. 1 indexed citations
2.
Vandermosten, Leen, Sofie Demeyer, Jan Cools, et al.. (2024). Single cell RNA sequencing reveals endothelial cell killing and resolution pathways in experimental malaria-associated acute respiratory distress syndrome. PLoS Pathogens. 20(1). e1011929–e1011929. 5 indexed citations
3.
Demeyer, Sofie, et al.. (2024). Unlocking the Complexity: Exploration of Acute Lymphoblastic Leukemia at the Single Cell Level. Molecular Diagnosis & Therapy. 28(6). 727–744. 1 indexed citations
4.
Gielen, Olga, et al.. (2024). Single-cell CRISPR screening characterizes transcriptional deregulation in T-cell acute lymphoblastic leukemia. Haematologica. 109(10). 3167–3181. 1 indexed citations
5.
Bempt, Marlies Vanden, Koen Debackere, Sofie Demeyer, et al.. (2022). Aberrant MYCN expression drives oncogenic hijacking of EZH2 as a transcriptional activator in peripheral T-cell lymphoma. Blood. 140(23). 2463–2476. 12 indexed citations
6.
Buijs-Gladdines, Jessica G. C. A. M., Valentina Cordo’, Willem K. Smits, et al.. (2021). MAPK-ERK is a central pathway in T-cell acute lymphoblastic leukemia that drives steroid resistance. Leukemia. 35(12). 3394–3405. 35 indexed citations
7.
Debackere, Koen, Lukas Marcelis, Sofie Demeyer, et al.. (2021). Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified. Nature Communications. 12(1). 3705–3705. 18 indexed citations
8.
Almeida, Afonso R. M., Sofie Demeyer, Thea Hogan, et al.. (2021). Overexpression of wild-type IL-7Rα promotes T-cell acute lymphoblastic leukemia/lymphoma. Blood. 138(12). 1040–1052. 28 indexed citations
9.
Verbeke, Delphine, Sofie Demeyer, Cristina Prieto, et al.. (2020). The XPO1 Inhibitor KPT-8602 Synergizes with Dexamethasone in Acute Lymphoblastic Leukemia. Clinical Cancer Research. 26(21). 5747–5758. 21 indexed citations
10.
Broux, Michaël, Cristina Prieto, Sofie Demeyer, et al.. (2019). Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia. Blood. 134(16). 1323–1336. 33 indexed citations
11.
Bock, Charles E. de, Sofie Demeyer, Sandrine Degryse, et al.. (2018). HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia Development. Cancer Discovery. 8(5). 616–631. 70 indexed citations
12.
Bie, Jolien De, Sofie Demeyer, Llucia Albertí Servera, et al.. (2018). Single-cell sequencing reveals the origin and the order of mutation acquisition in T-cell acute lymphoblastic leukemia. Leukemia. 32(6). 1358–1369. 63 indexed citations
13.
Dagklis, Antonis, Sofie Demeyer, Jolien De Bie, et al.. (2016). Hedgehog pathway activation in T-cell acute lymphoblastic leukemia predicts response to SMO and GLI1 inhibitors. Blood. 128(23). 2642–2654. 40 indexed citations
14.
Vercruysse, Thomas, Jolien De Bie, Jasper E. Neggers, et al.. (2016). The Second-Generation Exportin-1 Inhibitor KPT-8602 Demonstrates Potent Activity against Acute Lymphoblastic Leukemia. Clinical Cancer Research. 23(10). 2528–2541. 53 indexed citations
15.
Hornakova, Tekla, Sandrine Degryse, Olga Gielen, et al.. (2015). Distinct Acute Lymphoblastic Leukemia (ALL)-associated Janus Kinase 3 (JAK3) Mutants Exhibit Different Cytokine-Receptor Requirements and JAK Inhibitor Specificities. Journal of Biological Chemistry. 290(48). 29022–29034. 37 indexed citations
16.
Lierman, Els, Rikkert L. Snoeckx, Elizabeth H. Stover, et al.. (2010). Downstream effectors of FIP1L1-PDGFRA as targets for therapy in chronic eosinophilic leukemia. Haematologica. 95. 165–165. 1 indexed citations
17.
Bossuyt, Wouter, Avedis Kazanjian, Natalie De Geest, et al.. (2009). Atonal homolog 1 Is a Tumor Suppressor Gene. PLoS Biology. 7(2). e1000039–e1000039. 89 indexed citations
18.
Keersmaecker, Kim De, Idoya Lahortiga, Nicole Mentens, et al.. (2008). In vitro validation of  -secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia. Haematologica. 93(4). 533–542. 58 indexed citations
19.
Weisberg, Ellen, Andrew L. Kung, Renee D. Wright, et al.. (2007). Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells. Molecular Cancer Therapeutics. 6(7). 1951–1961. 66 indexed citations
20.
Ma, Zhong, Jan Cools, Peter Marynen, et al.. (1999). Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive ALK tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertil Johansson Breakdown of academic impact, for papers by Charlotte M. Niemeyer Breakdown of academic impact, for papers by Wolf‐Karsten Hofmann Breakdown of academic impact, for papers by Catriona Jamieson Breakdown of academic impact, for papers by Eunice S. Wang Breakdown of academic impact, for papers by Letizia Foroni Breakdown of academic impact, for papers by Brian J.P. Huntly Breakdown of academic impact, for papers by Ulrich Jaeger Breakdown of academic impact, for papers by Javier Pinilla‐Ibarz Breakdown of academic impact, for papers by Vincent H. J. van der Velden
Rankless by CCL
2026